A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants

NCT00655083 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Infantile Colic
Infantile Functional Gastrointestinal Disorders

Interventions

DRUG: Nepadutant
DRUG: Nepadutant

Sponsor

Menarini Group